To Estimate the Efficacy of Treatment With TNFi as Monotherapy or Combination Therapy With MTX and Compare and Contrast Efficacy With Tofacitinib as Monotherapy and Combination Therapy in a Real World Setting.

CompletedOBSERVATIONAL
Enrollment

1

Participants

Timeline

Start Date

June 4, 2015

Primary Completion Date

October 7, 2015

Study Completion Date

October 7, 2015

Conditions
Rheumatoid Arthritis
Interventions
OTHER

patterns of use of combination therapy and monotherapy

Trial Locations (1)

10017

Pfizer, New York

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT05576051 - To Estimate the Efficacy of Treatment With TNFi as Monotherapy or Combination Therapy With MTX and Compare and Contrast Efficacy With Tofacitinib as Monotherapy and Combination Therapy in a Real World Setting. | Biotech Hunter | Biotech Hunter